Serum antibodies to phosphatidylcholine in MS.
Maria Cruz SádabaVeit RothhammerÚrsula MuñozCristina SebalEsther EscuderoPia KivisäkkMaria Isabel Garcia SanchezGuillermo IzquierdoStephen L HauserSergio E BaranziniJorge R OksenbergRoberto Álvarez-LafuenteRohit BakshiHoward L WeinerFrancisco J QuintanaPublished in: Neurology(R) neuroimmunology & neuroinflammation (2020)
This study provides Class III evidence that serum antibodies to PC are elevated in patients with MS. The study is rated Class III because of the case control design and the risk of spectrum bias: antibody levels in patients with MS were compared with healthy controls.